Brigit Biofarmaka Teknologi Tbk. vs Royal Prima Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Royal Prima Tbk. trades at Rp98 (market cap 329.16B, 2.8M 24h volume). The key difference: Royal Prima Tbk. is the larger of the two by market cap, and Royal Prima Tbk. is more actively traded (2.8M versus 218.7K). Which is the better fit depends on your goals.
| OBAT | PRIM | |
|---|---|---|
Market Cap | 172.82B | 329.16B |
Volume | 218.7K | 2.8M |
Lot | 2.19K | 28.04K |
Turnover | 53.51M | 273.87M |
Average Price | 244.66 | 97.67 |
Value | 53.51M | 273.87M |
Indicative Equilibrium Price | 252 | 98 |
Indicative Equilibrium Volume | 48 | 153 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Royal Prima (the Company) was established based on notarial deed No. 1 dated 4 June 2013 of Heriyanti, S.H., M.Kn., notary in Medan.
Read more on PRIM →